1750387031

1750387031 was paid $3.57M by Medicaid between Jan 2018 and Apr 2023, across 105 billing codes. Its largest line is 99284, emergency room visit (serious) — 33% of everything it billed.

33Billing provider info1750387031

33aNPI1750387031

33bProvider type—

28Total paid$3.57M

24GClaims115,610

24DCodes billed105

24AFirst – last monthJan 2018 – Apr 2023

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	23,045	$568K
2019	18,155	$593K
2020	12,541	$459K
2021	22,983	$811K
2022	17,813	$650K
2023	21,073	$488K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	33%	10,606	9,339	$1.17M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	20%	7,354	6,781	$726K
96361	Intravenous infusion, hydration; each additional hour	13%	2,179	1,579	$471K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	11%	3,414	2,809	$400K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	4.5%	1,384	1,098	$162K
70450	Computed tomography, head or brain; without contrast material	2.9%	564	422	$104K
80048	Basic metabolic panel (calcium, ionized)	2.7%	13,227	11,332	$96K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	2.6%	1,223	1,019	$92K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.4%	1,138	1,087	$49K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	1,125	1,075	$31K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	211	125	$31K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	525	119	$26K

93 more codes

74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	129	$23K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	114	$20K
87480		<1%	553	$13K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	619	$11K
36415	Collection of venous blood by venipuncture	<1%	9,233	$11K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	218	$10K
84484		<1%	2,739	$10K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	15,674	$9K
71045	Radiologic examination, chest; single view	<1%	3,035	$9K
87660		<1%	584	$9K
87510		<1%	553	$8K
G0378	Hospital observation service, per hour	<1%	308	$8K
80053	Comprehensive metabolic panel	<1%	1,098	$7K
80076		<1%	1,770	$7K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	5,351	$6K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	3,697	$5K
71046	Radiologic examination, chest; 2 views	<1%	310	$3K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	41	$3K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	199	$3K
81001		<1%	6,947	$3K
84443	Thyroid stimulating hormone (TSH)	<1%	224	$3K
73030		<1%	79	$3K
80061	Lipid panel	<1%	170	$3K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	156	$2K
84439		<1%	95	$2K
83036	Hemoglobin; glycosylated (A1C)	<1%	122	$2K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	70	$2K
87481		<1%	120	$2K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	1,428	$1K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	57	$1K
72100		<1%	47	$1K
77063	Screening digital breast tomosynthesis, bilateral	<1%	30	$1K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	162	$1K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	26	$961.69
86902		<1%	31	$948.46
87086	Culture, bacterial; quantitative colony count, urine	<1%	349	$935.50
74018		<1%	57	$840.82
82553		<1%	64	$778.56
96375	Therapeutic injection; each additional sequential IV push	<1%	1,562	$754.34
85027		<1%	126	$684.80
73562		<1%	21	$674.89
83735		<1%	165	$635.63
87150		<1%	23	$603.09
83690		<1%	2,001	$435.07
83540		<1%	38	$396.01
97161		<1%	19	$391.02
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	1,261	$375.81
76000		<1%	60	$314.63
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	206	$296.32
85379		<1%	316	$279.32
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	18	$272.43
86850		<1%	13	$254.94
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	18	$240.93
86901		<1%	31	$235.90
85610		<1%	517	$232.61
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	16	$217.30
81025		<1%	573	$161.66
82150		<1%	562	$153.53
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	709	$150.00
86140		<1%	22	$129.08
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	48	$123.16
84703		<1%	191	$103.31
72125	Computed tomography, cervical spine; without contrast material	<1%	22	$97.33
83605		<1%	259	$96.96
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	88	$77.18
87186		<1%	91	$65.33
83880		<1%	78	$41.44
85730		<1%	296	$39.26
87081		<1%	14	$34.70
82550		<1%	81	$32.56
85652		<1%	16	$31.55
A9270	Non-covered item or service	<1%	1,343	$25.00
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	434	$18.75
J7120	Ringers lactate infusion, up to 1000 cc	<1%	340	$18.45
J2270	Injection, morphine sulfate, up to 10 mg	<1%	137	$17.82
J1170	Injection, hydromorphone, up to 4 mg	<1%	120	$16.96
J7030	Infusion, normal saline solution , 1000 cc	<1%	20	$15.20
J0690	Injection, cefazolin sodium, 500 mg	<1%	177	$15.18
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	524	$9.42
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	292	$8.30
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	62	$6.19
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	316	$1.82
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	246	$1.02
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	39	$0.30
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	73	$0.00
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	0%	31	$0.00
77067	Screening mammography, bilateral, including computer-aided detection	0%	30	$0.00
94760		0%	2,107	$0.00
J2704	Injection, propofol, 10 mg	0%	290	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	86	$0.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	13	$0.00
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	0%	13	$0.00
96376		0%	47	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.